India Biomanufacturing Market Insights Forecasts to 2033

• The Market is growing at a CAGR of 6.8% from 2023 to 2033
• The India Biomanufacturing Market Size is Expected to Hold a Significant Share by 2033

The India Biomanufacturing Market is Anticipated to Hold a Significant Share by 2033, growing at a CAGR of 6.8% from 2023 to 2033.

Market Overview

Biomanufacturing is the production aspect of the biotechnology sector. The process involves creating goods using living organisms like microorganisms, animal cells, or plant cells. These cells can either be found naturally or they are usually modified genetically to create the desired substance. Proteins or nucleic acids in medications, enzymes in the food sector, and biodegradable bioplastics made by bacteria are all instances of biomanufactured biomolecules. The pharmaceutical sector utilizes biomanufacturing to create the active medicinal components that will be transformed into the end product known as a biological drug. Proteins like antibodies, cytokines, hormones, and enzymes are active drug molecules. Manufacturing biomolecules involves using cell culture for cells to create the active drug (upstream processing) and purification techniques like chromatography and filtration to separate the substance from contaminants (downstream processing). The quick expansion of the biopharmaceutical sector mirrors the growing importance of biomanufacturing as the main method for creating and manufacturing biological products, which is referred to as the next-generation biomanufacturing market.

Report Coverage

This research report categorizes the market for the India biomanufacturing market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the India biomanufacturing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the India biomanufacturing market.

Driving Factors

Factors such as the expansion of the worldwide biopharmaceutical industry, heightened commercialization and pipeline growth, utilization of cutting-edge technology, and fresh advancements in design, efficiency, performance, and other sectors are expected to drive the growth of the future biomanufacturing market. Conversely, the increase in funding from both government and private entities for new technology development will enhance opportunities for growth in the biomanufacturing market in the coming years. Increasing environmental worries, pollution levels, water scarcity, and efficient medical production services will drive growth in the global biomanufacturing market.

Restraining Factors

Factors such as significant capital investment, unpredictable expenses, shortage of skilled workers, operational intricacies, and compatibility issues are some of the obstacles that impede market expansion.

Market Segmentation

The India biomanufacturing market share is classified into product and application.

• The downstream biomanufacturing segment is expected to hold the largest market share through the forecast period.   

The India biomanufacturing market is segmented, by product into continuous upstream biomanufacturing, single-use upstream biomanufacturing, and downstream biomanufacturing. Among these, the downstream biomanufacturing segment is expected to hold the largest market share through the forecast period. This section includes crucial procedures like refining, filtering, and ultimately preparing biopharmaceutical products. The importance of downstream processes in maintaining the quality and effectiveness of biomanufactured products, along with the rising need for advanced biologics and biosimilars, is a key factor driving its popularity in the market.

• The monoclonal antibodies segment dominates the market with the largest market share over the predicted period.

The India biomanufacturing market is segmented by application into monoclonal antibodies, hormones, vaccines, recombinant proteins, and others. Among these, the monoclonal antibodies segment dominates the market with the largest market share over the predicted period. Their widespread application in the treatment of different illnesses, such as cancer, autoimmune disorders, and chronic conditions, contributes to their prevailing influence. Monoclonal antibodies play a significant role in the advancement of novel drug development and personalized medicine, leading to their dominant position in the market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the India biomanufacturing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Biocon Limited
• Serum Institute of India
• Dr. Reddy’s Laboratories
• Cipla Limited
• Lupin Pharmaceuticals
• Wockhardt Limited
• Hikma Pharmaceuticals
• Zydus Cadila
• Glenmark Pharmaceuticals
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In August 2024, In the Interim Budget, the Finance Minister of India introduced the BioE3 policy, which includes a new initiative for bio-manufacturing and bio-foundry to offer eco-friendly options like biodegradable polymers, bio-plastics, biopharmaceuticals, and bio agri inputs.

Market Segment

This study forecasts revenue at India, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the India Biomanufacturing Market based on the below-mentioned segments:

India Biomanufacturing Market, By Product

• Continuous Upstream Biomanufacturing
• Single-Use Upstream Biomanufacturing
• Downstream Biomanufacturing

India Biomanufacturing Market, By Application

• Monoclonal Antibodies
• Hormones
• Vaccines
• Recombinant Proteins
• Others